Corticosteroids in polymyalgia rheumatica--a review of different treatment schedules
Li, C.; Dasgupta, B.
Clinical and Experimental Rheumatology 18(4 Suppl 20: S56-S57
2000
ISSN/ISBN: 0392-856X PMID: 10948765 Document Number: 516929
Low dose oral steroids (prednisolone 10-15 mg daily) are currently advocated for the treatment of uncomplicated PMR and the dose should be carefully adjusted in relation to disease activity. Intramuscular methylprednisolone has been shown to have a similar remission rate to oral steroids and a better side effect profile with respect to fracture rate and weight gain. Prophylaxis for osteoporosis at least with calcium and vitamin D should be initiated at the start of steroid therapy.